• Medientyp: E-Artikel
  • Titel: Influence of COVID-19 on the notification of drug-resistant pulmonary tuberculosis cases
  • Beteiligte: Orfão, Nathalia Halax; Andrade, Rubia Laine de Paula; Ruffino-Netto, Antônio; da Silva, Leila Wiedmann Florentino; Villa, Tereza Cristina Scatena; Seifert, Marva Lynn; Zilly, Adriana; Arcoverde, Marcos Augusto Moraes; Hoare, Ismael; Izurieta, Ricardo; da Silva-Sobrinho, Reinaldo Antônio
  • Erschienen: Springer Science and Business Media LLC, 2023
  • Erschienen in: BMC Infectious Diseases
  • Sprache: Englisch
  • DOI: 10.1186/s12879-023-08463-x
  • ISSN: 1471-2334
  • Schlagwörter: Infectious Diseases
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>To analyze the influence of the COVID-19 pandemic on the process of diagnosis and monitoring of drug-resistant pulmonary tuberculosis (TB) cases reported in the state of Paraná, Brazil, from 2015 to 2020.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Ecological study with quantitative approach. This study was based on diagnosed cases of pulmonary TB reported in the Notifiable Disease Information System in residents of Paraná; as well as through the number of confirmed cases of COVID-19 in the state epidemiological bulletin for the year 2020. The study data were analyzed using descriptive statistics.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>It was found that, although the number of reported pulmonary TB cases (drug-resistant and general) increased between 2015 and 2019, there was a drop in notification in 2020, the first year of the COVID-19 pandemic. The notification of TB cases was also influenced monthly during the year according to the increase in the number of COVID-19 cases. For cases of drug-resistant pulmonary TB, the provision of diagnostic tests and Directly Observed Treatment decreased by more than half in 2020, especially when compared to 2019.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>In view of these findings, the influence of COVID-19 on the diagnosis and monitoring of drug-resistant and general pulmonary TB cases is evident, showing that the pandemic has compromised the advances of recent decades in achieving the goals established for its eradication by 2035.</jats:p> </jats:sec>
  • Zugangsstatus: Freier Zugang